| Literature DB >> 30506794 |
Kun Liang1, Davide Brambilla2, Jean-Christophe Leroux3.
Abstract
Additive manufacturing (AM) is a fast-growing manufacturing approach that comes with the promise of delivering personalized medicine to treat individual patients. However, large-scale commercial applications in the pharmaceutical industry have been limited. Here, some of the challenges are discussed along with some pharmaceutical products where AM has the potential to make a tangible impact and pave the way for more rapid adoption are highlighted.Entities:
Keywords: 3D printing; drug delivery; pharmaceuticals
Mesh:
Substances:
Year: 2018 PMID: 30506794 DOI: 10.1002/adma.201805680
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849